About The Medical Condition MDL17,043
Find the definition of the medical term MDL17,043. MDL17,043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
MDL17,043
| MDL17,043 Medical Condition |
|---|
What's The Definition Of The Medical Condition MDL17,043?
1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Hospitals, Proprietary ‐ Hospitals owned and operated by a corporation or an individual…
- Myxedemas, Congenital ‐ A condition due to congenital lack of thyroid hormone, marked…
- Ketosuccinates ‐ Salts and esters of…
- Cross Reaction ‐ Serological reactions in which an antiserum against one antigen…
- Venoms, Scorpion ‐ Venoms from animals of the order Scorpionida of the class Arachnida.…
- Neoplasms, Ureter ‐ Cancer or tumors of the URETER. Hematuria, which occurs in 75%…
- Antagonists, Blood Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
- Carminomicin ‐ A very toxic anthracycline-type antibiotic related to DAUNORUBICIN,…
- Elbow, Tennis ‐ A condition characterized by pain in or near the lateral humeral…
- Tryptan ‐ An essential amino acid that is necessary for normal growth in…